Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
David E. Kandzari(Piedmont Atlanta Hospital), George L. Bakris(Pennsylvania State System of Higher Education), Laura P. Svetkey(Duke University), Joseph M. Massaro(Boston University), Deepak L. Bhatt(Mount Sinai Hospital), Murray Esler(Baker Heart and Diabetes Institute), Manesh R. Patel(Duke University), David P. Lee(APLA Health), Krishna J. Rocha‐Singh(St. John's Hospital), Raymond R. Townsend(University of Pennsylvania), Martin Fahy(Medtronic (United States)), Janice P. Lea, Barry T. Katzen(Baptist Hospital of Miami), Laura Mauri(Brigham and Women's Hospital), Paul A. Sobotka(The Ohio State University), Chandan Devireddy, Sandeep Brar(Medtronic (United States)), Martin B. Leon(Columbia University Irving Medical Center), Adrian Ma(Stanford Health Care), William W. O’Neill(Henry Ford Health System), John M Flack(Wayne State University), Suzanne Oparil(University of Alabama at Birmingham)
Cited by 540
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
General Cardiovascular Risk Profile for Use in Primary Care
|Circulation|2008|7.4k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k